Clinical Trial Update: Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the tissue distribution of F18-FDG labeled autologous bone marrow–derived stem cells in patients with Type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow-derived stem cells labeled with F18-FDG

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: UNKNOWN